Longevity & AgingResearch PaperPaywall

Dual Antioxidant Hydrogel Scaffold Supercharges Bone Defect Repair

A cerium-resveratrol composite hydrogel tackles oxidative stress at bone defect sites, boosting osteoblast growth and accelerating repair.

Saturday, May 9, 2026 0 views
Published in ACS Appl Mater Interfaces
Glowing molecular lattice of cerium framework embedded in translucent hydrogel scaffold, with new bone tissue forming at edges

Summary

Researchers developed a gelatin/alginate hydrogel scaffold loaded with cerium metal-organic frameworks and resveratrol to tackle large bone defects. The scaffold targets oxidative stress — a key barrier to bone healing — using two complementary antioxidants. Cerium ions in their multivalent states scavenge reactive oxygen species and improve mitochondrial function, while resveratrol adds polyphenol-based antioxidant support. A polydopamine coating enhances structural stability. Lab tests confirmed strong biocompatibility, ROS clearance, and osteoblast proliferation and differentiation. Animal studies supported these findings, showing improved bone defect repair in vivo. The approach offers a promising biomaterial platform for orthopedic applications where traditional bone substitutes fall short.

Detailed Summary

Large bone defects represent one of orthopedics' most persistent challenges. Traditional bone substitutes suffer from limited availability and poor structural compatibility, leaving surgeons with inadequate options for complex reconstructions. Novel biomaterials that actively shape the healing microenvironment are urgently needed.

This study introduced a composite scaffold built on a gelatin/alginate dual-network hydrogel (Gel/AlgMA), fabricated via photopolymerization. The scaffold was loaded with two antioxidant agents: cerium-based metal-organic frameworks (Ce-UiO-66) and resveratrol (Res). A polydopamine (PDA) coating was applied to improve the cerium framework's stability and biointegration, yielding the final Gel/Alg@Ce-Res/PDA composite.

The rationale centers on oxidative stress. At bone defect sites, excess reactive oxygen species impair osteoblast function and delay healing. Ce-UiO-66 mimics enzymatic antioxidants through cerium's Ce³⁺/Ce⁴⁺ redox cycling, continuously neutralizing ROS and protecting mitochondrial integrity. Resveratrol, a well-characterized plant polyphenol with antioxidant and anti-inflammatory properties, provides complementary free-radical scavenging through a distinct molecular mechanism — hence the 'dual' antioxidant designation.

In vitro results demonstrated effective ROS scavenging, reduced oxidative stress markers, and enhanced osteoblast proliferation and differentiation. In vivo experiments in bone defect models corroborated these effects, showing favorable new bone formation. The scaffold's hydrogel matrix also supports cell infiltration and nutrient diffusion.

While the findings are encouraging, the study relied on animal models and cell culture, so translation to human clinical use requires further validation. Long-term degradation behavior, immune responses, and load-bearing performance in humans remain to be characterized. Nonetheless, this dual-antioxidant biomaterial strategy represents a meaningful advance in regenerative orthopedics.

Key Findings

  • Ce-UiO-66 cerium frameworks scavenge ROS via Ce³⁺/Ce⁴⁺ redox cycling, protecting mitochondrial function at defect sites.
  • Resveratrol provides complementary polyphenol-based antioxidant activity, creating a dual-mechanism oxidative stress defense.
  • Polydopamine coating improved scaffold stability and biointegration without compromising antioxidant performance.
  • Composite scaffold promoted osteoblast proliferation and differentiation in vitro with strong biocompatibility.
  • In vivo animal experiments confirmed enhanced bone defect repair compared to controls.

Methodology

A gelatin/alginate dual-network hydrogel was fabricated via photopolymerization and loaded with Ce-UiO-66 and resveratrol, then coated with polydopamine. In vitro assays evaluated biocompatibility, ROS scavenging, and osteoblast behavior; in vivo bone defect models assessed regenerative efficacy.

Study Limitations

Findings are based on cell culture and animal models, limiting direct extrapolation to human patients. Long-term in vivo degradation, immune compatibility, and mechanical performance under physiological loading conditions have not been fully characterized. Only the abstract was available for analysis, restricting depth of methodological appraisal.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.